Cover - shares |
12 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Jul. 15, 2026 |
|
| Entity Addresses [Line Items] | ||
| Document Type | 20-F/A | |
| Amendment Flag | true | |
| Amendment Description | This Amendment No. 1 on Form 20-F/A (the “Amended Annual Report”) amends the Annual Report on Form 20-F of OKYO Pharma Limited (the “Company” or “we”) for the year ended March 31, 2026 (the “Original Form 20-F”), filed on July 20, 2026, with the Securities and Exchange Commission (the “SEC”). The only changes made to the Original Form 20-F are to revise the Exhibit Table to include the Company’s Clawback policy, which was erroneously omitted from the previous filing. Except as noted above, the Company has not modified, or updated disclosures presented in this Amended Annual Report. Accordingly, the Amended Annual Report does not reflect events occurring after the Original Form 20-F or modify or update those disclosures affected by subsequent events. | |
| Document Registration Statement | false | |
| Document Annual Report | true | |
| Document Transition Report | false | |
| Document Shell Company Report | false | |
| Document Period End Date | Mar. 31, 2026 | |
| Document Fiscal Period Focus | FY | |
| Document Fiscal Year Focus | 2026 | |
| Current Fiscal Year End Date | --03-31 | |
| Entity File Number | 001-41386 | |
| Entity Registrant Name | OKYO Pharma Limited | |
| Entity Central Index Key | 0001849296 | |
| Entity Incorporation, State or Country Code | Y7 | |
| Entity Address, Address Line One | OKYO Pharma Limited | |
| Entity Address, Address Line Two | Martello Court | |
| Entity Address, Address Line Three | Admiral Park | |
| Entity Address, City or Town | St. Peter Port | |
| Entity Address, Country | GG | |
| Entity Address, Postal Zip Code | GY1 3HB | |
| Entity Well-known Seasoned Issuer | No | |
| Entity Voluntary Filers | No | |
| Entity Current Reporting Status | Yes | |
| Entity Interactive Data Current | Yes | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Emerging Growth Company | true | |
| Elected Not To Use the Extended Transition Period | false | |
| Document Accounting Standard | International Financial Reporting Standards | |
| Entity Shell Company | false | |
| Entity Common Stock, Shares Outstanding | 52,479,527 | |
| ICFR Auditor Attestation Flag | false | |
| Document Financial Statement Error Correction [Flag] | false | |
| Business Contact [Member] | ||
| Entity Addresses [Line Items] | ||
| Entity Address, Address Line One | 107 Cheapside | |
| Entity Address, City or Town | London | |
| Entity Address, Country | GB | |
| Entity Address, Postal Zip Code | EC2V 6DN | |
| City Area Code | +44 | |
| Local Phone Number | 20 7495 2379 | |
| Contact Personnel Name | Chief Financial Officer | |
| Contact Personnel Email Address | kshah@okyopharma.com |